Skip to main content
APMD
NASDAQ Life Sciences

Apnimed IPO Prices at $16 High End, Upsized to $192M, Shares Jump

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.95
Mkt Cap
--
52W Low
--
52W High
--
52W Position
Off High
Rel. Volume
Market data snapshot near publication time

Summary

Apnimed priced its IPO at $16 per share, the top of the $14-$16 range, and upsized the deal to 12 million shares from 10 million, raising $192 million. The stock opened at $22.00, a 37.5% pop, and was recently at $17.38, up 8.6%. Strong demand and pricing at the high end signal investor appetite for the clinical-stage pharma company. The upsized deal and initial trading pop provide a positive read-through for biotech IPO sentiment.

At the time of this announcement, APMD was trading at $18.95 on NASDAQ in the Life Sciences sector. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

APMD - Latest Insights

APMD
Nov 13, 2026, 4:45 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.92
Real-time Price: $16.92 info
Change: $0 (0%) info
Market Cap: $704.393M info
APMD
Sep 08, 2026, 5:12 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $28.79
Real-time Price: $16.92 info
Change: -$11.87 (-41%) info
Market Cap: $704.393M info
APMD
Sep 08, 2026, 5:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $28.79
Real-time Price: $16.92 info
Change: -$11.87 (-41%) info
Market Cap: $704.393M info
APMD
Sep 08, 2026, 4:39 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $28.79
Real-time Price: $16.92 info
Change: -$11.87 (-41%) info
Market Cap: $704.393M info
APMD
Aug 03, 2026, 4:35 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $25.00
Real-time Price: $16.92 info
Change: -$8.08 (-32%) info
Market Cap: $704.393M info